Pharmaceutical residues risks need to be evaluated, says report
A new report has said the majority of the active ingredients used in pharmaceuticals have never been evaluated for environmental risks.
List view / Grid view
A new report has said the majority of the active ingredients used in pharmaceuticals have never been evaluated for environmental risks.
The PI System serves as a single source of truth for all operational data, enabling pharmaceutical companies to design the right supply chain to meet business goals.
Thirteen winners have been announced for the 2019 CPhI Pharma Awards including Dr Ge Li for ‘CEO of the Year’ and a ‘Lifetime Achievement' award for John Chiminski.
Lonza Pharma & Biotech is the leader in capsule-based solutions and services, proudly offering Capsugel® products.
2 October 2019 | By SUEZ – Ozonia® Ozone Systems
This webinar guides you through efficiency gains with TOC for cleaning validation. We call it a ‘beginner’s guide’, but the session will benefit long-time TOC users as well as those new to using TOC for cleaning validation.
In February this year the EU Falsified Medicines Directive (FMD) came into effect. Rich Quelch assesses this latest regulatory attempt to rid the supply chain of dangerous falsified products and reflects on the industry’s need to keep ahead of the game to future-protect itself.
Confirming product authenticity, combating counterfeiting and preventing product diversion are key for compliance within the global supply chain. This whitepaper focuses on pharmaceutical serialisation and solutions to combat producers of counterfeit products.
The successful pilot programme could represent an important step forward in biopharmaceutical supply chain innovation.
The European Regulatory Framework for Medical Device field is changing with the release of the new Regulation. The MDR will replace the existing Directives and it will be fully in force in May 2020.
Emirates SkyCargo has commenced handling pharmaceutical cargo at a new purpose-built facility in Chicago.
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
British Columbia has said it will switch as many as 20,400 patients from three branded biologic drugs to cheap biosimilars.
With the UK bracing itself for a 'no-deal' Brexit or some other outcome that has not yet been determined, pharma experts discussed the potential effect of Brexit on the supply chain and how to best prepare for it against the upcoming deadline.
FDA has launched a notification system where device manufacturers and users may notify the agency of any shortages or related supply issues stemming from sterilisation facility shutdowns...
Regulatory expectations nowadays focus on harmonisation of global regulations. This whitepaper by PQE looks at current and emerging trends in regulatory expectations.